Therapeutic strategies for locally recurrent and metastatic de-differentiated liposarcoma with herpes simplex virus–thymidine kinase–expressing mesenchymal stromal cells-Reference-Cited by-同舟云学术

Therapeutic strategies for locally recurrent and metastatic de-differentiated liposarcoma with herpes simplex virus–thymidine kinase–expressing mesenchymal stromal cells

Published:2017-09 Issue:9 Volume:19 Page:1035-1047
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Lee Hyunjoo,Jo Eun Byeol,Kim Su Jin,Yang Heung Mo,Kim You Min,Sung Young Chul,Park Jae Berm,Hong Doopyo,Park Hyojun,Choi Yoon-La,Kim Sung Joo

Funder

Ministry of Education, Science and Technology

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference31 articles.

1. Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial results;Tseng;Cancers (Basel),2013

2. New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort;Hoffman;Drug Resist Updat,2011

3. An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors;Peng;Lab Invest,2011

4. Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy;Liu;Ann Surg Oncol,2012

5. Mesenchymal stem cells engineered for cancer therapy;Shah;Adv Drug Deliv Rev,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cause and consequence of heterogeneity in human mesenchymal stem cells: Challenges in clinical application;Pathology - Research and Practice;2024-08

2. Intravenously Infused Stem Cells for Cancer Treatment;Stem Cell Reviews and Reports;2021-06-17

3. Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells;BMC Cancer;2019-05-24

4. Establishment of a Novel PDX Mouse Model and Evaluation of the Tumor Suppression Efficacy of Bortezomib Against Liposarcoma;Translational Oncology;2019-02

5. Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour;International Journal of Molecular Sciences;2018-07-27